Literature DB >> 20669974

Synthesis, processing and solid state excipient interactions of cucurbit[6]uril and its formulation into tablets for oral drug delivery.

Shonagh Walker1, Rajdip Kaur, Fiona J McInnes, Nial J Wheate.   

Abstract

The synthesis, processing, and solid state excipient interactions of cucurbit[6]uril (CB[6]) and its formulation into oral tablets has been examined using a range of physical chemistry techniques. Rapid precipitation from HCl by the addition of water yields microcrystalline CB[6] with smaller and more consistent particle size (30-165 μm) compared with the sieved CB[6] (50-540 μm) produced from large crystals grown by slow evaporation from HCl. The microcrystalline particles also contain fewer water molecules in the crystal compared with the sieved particles: 10 and 16% respectively. Microcrystalline CB[6] can be formulated into tablets suitable for oral delivery with a CB[6] content of 1-50% w/w, with the other excipients including lactose, talc, Avicel, magnesium stearate and Ac-Di-Sol. In the solid state microcrystalline CB[6] does not interact significantly with the talc, Ac-Di-Sol or Avicel, but significant interactions are observed when mixed or ground with either magnesium stearate or lactose, resulting in the lowering of the melting points of both excipients. This work represents the first study of the physical processing and solid state chemistry of CB[n]s for pharmaceutical formulation and represents an important development step in the use of CB[n]s as drug delivery vehicles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20669974     DOI: 10.1021/mp100191b

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.

Authors:  Gaya Hettiarachchi; Soumen K Samanta; Shane Falcinelli; Ben Zhang; Damien Moncelet; Lyle Isaacs; Volker Briken
Journal:  Mol Pharm       Date:  2016-01-22       Impact factor: 4.939

2.  Synthesis of a Disulfonated Derivative of Cucurbit[7]uril and Investigations of its Ability to Solubilize Insoluble Drugs.

Authors:  Elizabeth L Robinson; Peter Y Zavalij; Lyle Isaacs
Journal:  Supramol Chem       Date:  2015-05-01       Impact factor: 1.688

3.  In vivo hyperCEST imaging: Experimental considerations for a reliable contrast.

Authors:  Christian T McHugh; Michele Kelley; Nicholas J Bryden; Rosa T Branca
Journal:  Magn Reson Med       Date:  2021-10-02       Impact factor: 4.668

4.  Magnetic Resonance Detection of Gas Microbubbles via HyperCEST: A Path Toward Dual Modality Contrast Agent.

Authors:  Christian T McHugh; Phillip G Durham; Michele Kelley; Paul A Dayton; Rosa T Branca
Journal:  Chemphyschem       Date:  2021-05-19       Impact factor: 3.520

5.  Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.

Authors:  Marian Seif; Michael L Impelido; Michael G Apps; Nial J Wheate
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

6.  Co-grinding Effect on Crystalline Zaltoprofen with β-cyclodextrin/Cucurbit[7]uril in Tablet Formulation.

Authors:  Shanshan Li; Xiang Lin; Kailin Xu; Jiawei He; Hongqin Yang; Hui Li
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

Review 7.  Applications of Cucurbiturils in Medicinal Chemistry and Chemical Biology.

Authors:  Debapratim Das; Khaleel I Assaf; Werner M Nau
Journal:  Front Chem       Date:  2019-09-13       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.